Inion Signs Three-Year Development Agreement with University of Cambridge

Collaboration with Medical Materials Group to extend next-generation bioactive materials platform

14-Nov-2005

Inion has entered into a three-year collaboration agreement with The Cambridge Centre for Medical Materials at the University of Cambridge Department of Materials Science & Metallurgy. The collaboration will focus on developing a new medical materials platform combining the proprietary Inion Optima[TM] biodegradable polymers with nano-phase bioactive ceramics under development at the University.

These new Biodegradable Bioactive Nano Composite (BBNC) materials are complementary to Inion's own Optima PLUS[TM] bioactive platform in development, which combines Inion Optima[TM] polymers with N-methyl-pyrollidone (NMP). In time it is expected that both platforms will be used to manufacture innovative medical fixation devices for a broad range of clinical applications.

The Cambridge Centre for Medical Materials (CCMM) is world-renowned in the field of innovative medical materials. The centre was set up in 2000 by Prof. William Bonfield, at the University of Cambridge, Department of Materials Science and Metallurgy, and has strong links with the prestigious Orthopaedic Research Unit, headed by Prof. Neil Rushton, Professor of Orthopaedics at Addenbrooke's Hospital.

The co-directors of CCMM, Dr Serena Best and Dr Ruth Cameron, and their research team are among the most highly regarded in the field of therapeutic materials, and the group's research has pioneered the development of bioactive technologies to promote tissue healing.

Inion will make a small financial contribution to the collaboration and has taken a non-exclusive, non-royalty bearing licence for commercialising any resulting products. The Company has an option to make the licence exclusive in return for making royalty payments on future product sales. The University of Cambridge will retain intellectual property rights to the use of the technology it is contributing to this collaboration.

https://www.bionity.com/en/news/50168/inion-signs-three-year-development-agreement-with-university-of-cambridge.html